Skip to main content
. 2019 Jun 3;13(9):761–771. doi: 10.2217/bmm-2018-0441

Figure 2. . Kaplan-Meier analysis of non-small cell lung carcinomas patients with differential p16 and p53expression and high-risk human papilloma virus status.

Figure 2. 

(A) Overall survival of p16 positive and negative tumors in ADC patients (p = 0.048); (B) overall survival of p16 positive and negative tumors in SQCC patients (p = 0.190); (C) overall survival of p53 positive and negative tumors in ADC patients (p = 0.846); (D) overall survival of p53 positive and negative tumors in SQCC patients (p = 0.701); (E) overall survival of p16/HPV positive and negative tumors in ADC patients (p = 0.013); and (F) overall survival of p16/HPV positive and negative tumors in SQCC patients (p = 0.343).

ADC: Adenocarcinoma; HPV: Human papillomavirus; SQCC: Squamous cell carcinoma.